Direct-to-Biology (D2B) Applications for Degrader and Small Molecule Lead Generation

Name: Direct-to-Biology (D2B) Applications for Degrader and Small Molecule Lead Generation
Start: 2026-11-10T18:15
End: 2026-11-10T19:15
Location: Intercontinental Barcelona

Drug Discovery Chemistry Europe 2026 · 10 November 2026 · 18:15–19:15

Direct-to-Biology (D2B) Applications for Degrader and Small Molecule Lead Generation was a session at Drug Discovery Chemistry Europe 2026 on 10 November 2026 in Barcelona, with 2 speakers on record.

Speakers

Ryan A. Hollibaugh — Moderator Associate Director, Jnana Therapeutics
Sam M. Rowe — Moderator Investigator, GSK